WILLIAM F DOYLE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILLIAM F DOYLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILLIAM F DOYLE. WILLIAM F DOYLE is a Director in OptiNose, Inc. ($OPTN) and a Director in Minerva Neurosciences, Inc. ($NERV) and a Director in Novocure Ltd ($NVCR) and an Executive Chairman in Novocure Ltd ($NVCR).
Address: C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK 07932 NJ
Companies in which WILLIAM F DOYLE is an Insider
Minerva Neurosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM F DOYLE: Director
Holdings: 26,111 shares
Current Value: $265,027
Latest Transaction: Jun 15 2021
$NERV Market Capitalization: $346.33M
$NERV Previous Close: $10.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NovoCure Ltd
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of WILLIAM F DOYLE: Executive Chairman, Director
Holdings: 648,993 shares
Current Value: $4,413,152
Latest Transaction: Apr 15 2021
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OptiNose, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILLIAM F DOYLE: Director
Holdings: 817,225 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of WILLIAM F DOYLE
Sentiment: All, NERV, NVCR, OPTN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | NERV | Minerva Neuroscien ... | DOYLE WILLIAM F | Director | Option Exercise | A | 2.90 | 40,000 | 116,000 | 40,000 | |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 216.69 | 600 | 130,016 | 555,393 | 556 K to 555.4 K (-0.11 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 214.67 | 500 | 107,333 | 555,993 | 556.5 K to 556 K (-0.09 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 213.35 | 1,500 | 320,021 | 556,493 | 558 K to 556.5 K (-0.27 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 211.28 | 600 | 126,766 | 557,993 | 558.6 K to 558 K (-0.11 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 210.18 | 521 | 109,504 | 558,593 | 559.1 K to 558.6 K (-0.09 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 209.34 | 2,200 | 460,555 | 559,114 | 561.3 K to 559.1 K (-0.39 %) |